A protective role for protease-activated receptors in the airways

[1]  J. Szarek,et al.  Substance P and capsaicin release prostaglandin E2 from rat intrapulmonary bronchi. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[2]  Robert V Farese,et al.  A dual thrombin receptor system for platelet activation , 1998, Nature.

[3]  Scott R. Presnell,et al.  Cloning and characterization of human protease-activated receptor 4. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Steinhoff,et al.  Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. , 1998, American journal of physiology. Cell physiology.

[5]  S. M. Baker,et al.  Characterization of Protease-activated Receptor-2 Immunoreactivity in Normal Human Tissues , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  M. Hollenberg,et al.  Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  F. Hirahara,et al.  Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study. , 1997, Human pathology.

[8]  Patricia Andrade-Gordon,et al.  Endothelial Cell Thrombin Receptors and PAR-2 , 1997, The Journal of Biological Chemistry.

[9]  S. Coughlin,et al.  Protease-activated receptor 3 is a second thrombin receptor in humans , 1997, Nature.

[10]  T. Cocks,et al.  Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium‐dependent relaxation to bradykinin in human small resistance‐like coronary arteries , 1997, British journal of pharmacology.

[11]  D. Payan,et al.  Mechanisms of Desensitization and Resensitization of Proteinase-activated Receptor-2* , 1996, The Journal of Biological Chemistry.

[12]  R. Scarborough,et al.  Ligand Cross-reactivity within the Protease-activated Receptor Family* , 1996, The Journal of Biological Chemistry.

[13]  S. Coughlin,et al.  Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. , 1996, The Biochemical journal.

[14]  J. Stoller,et al.  Lung disease due to α1 -antitrypsin deficiency , 1996 .

[15]  I. Pavord,et al.  Bronchoprotective role for endogenous prostaglandin E2 , 1995, The Lancet.

[16]  C. Wahlestedt,et al.  Molecular cloning of a potential proteinase activated receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Coughlin.  Thrombin receptor function and cardiovascular disease. , 1994, Trends in cardiovascular medicine.

[18]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[19]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[20]  N. Choudry,et al.  Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine. , 1989, The American review of respiratory disease.

[21]  P. O'Byrne,et al.  Tachyphylaxis to inhaled histamine in asthmatic subjects. , 1987, Journal of applied physiology.

[22]  P. O'Byrne,et al.  The effect of indomethacin on exercise-induced bronchoconstriction and refractoriness after exercise. , 1986, The American review of respiratory disease.